EUVIMEDEUVIMED entdecken
Crossref

Treatment failure is a key factor in the development of Helicobacter pylori resistance

Jinliang Xie, Jianxiang Peng, Dingwei Liu, Rong Zeng, Jiayu Qiu, Liting Shen, Xiaomin Gong, Dongsheng Liu, Yong Xie

Helicobacter · 2024

DOI: 10.1111/hel.13091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Helicobacter, 2024. Verfasst von Jinliang Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Ji…. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Treatment Failure, Anti-Bacterial Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Helicobacter pylori eradication failure influences its antibiotic resistance.

Aims

This study aimed to evaluate the effect of previous treatment failures on it, including the changes in the antibiotic resistance rates, minimal inhibitory concentration (MIC) distributions, and resistance patterns. Materials and Methods This single‐center retrospective study included 860 primary isolates and 247 secondary isolates. Antibiotic susceptibility testing was performed for amoxicillin, metronidazole, clarithromycin, levofloxacin, furazolidone, tetracycline, and rifampicin. The demographic data and detailed regimens were collected.

Results

The primary resistance rates to amoxicillin, metronidazole, clarithromycin, levofloxacin, tetracycline, rifampin, and furazolidone were 5.93%, 83.84%, 28.82%, 26.28%, 0.35%, 1.16%, and 0%, while secondary were 25.10%, 92.31%, 79.76%, 63.16%, 1.06%, 3.19%, and 0%, respectively. The resistance rates to amoxicillin, metronidazole, clarithromycin, and levofloxacin increased significantly with the number of treatment failures accumulated, and showed a linear trend. The proportion of primary and secondary multidrug‐resistant (MDR) isolates were 17.79% and 63.16%, respectively. The MIC values of amoxicillin, clarithromycin, and levofloxacin were elevated significantly with medication courses increased.

Conclusion

The prevalence of amoxicillin, clarithromycin, levofloxacin, and metronidazole resistance would increase rapidly following first‐line treatment failure, as well as the MIC values of them. Clinicians should pay great attention to the first‐line treatment to cure H. pylori infection successfully.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsTreatment FailureAnti-Bacterial AgentsMicrobial Sensitivity TestsHumansRetrospective StudiesFemaleMaleMiddle AgedAdultAgedDrug Resistance, BacterialYoung AdultAdolescentAged, 80 and over

Stichwörter der Autor:innen

Helicobacter pyloriantibiotic resistancefirst‐line treatmentmedication coursesminimal inhibitory concentration

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.
  • Jiangxi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi Province, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xie, J., Peng, J., Liu, D., Zeng, R., Qiu, J., Shen, L., Gong, X., Liu, D., & Xie, Y. (2024). Treatment failure is a key factor in the development of Helicobacter pylori resistance. Helicobacter. https://doi.org/10.1111/hel.13091

Vancouver

Xie J, Peng J, Liu D, Zeng R, Qiu J, Shen L, et al. Treatment failure is a key factor in the development of Helicobacter pylori resistance. Helicobacter. 2024. doi:10.1111/hel.13091

BibTeX
@article{Xie2024,
  author = {Xie, Jinliang and Peng, Jianxiang and Liu, Dingwei and Zeng, Rong and Qiu, Jiayu and Shen, Liting and Gong, Xiaomin and Liu, Dongsheng and Xie, Yong},
  title = {Treatment failure is a key factor in the development of Helicobacter pylori resistance},
  journal = {Helicobacter},
  year = {2024},
  doi = {10.1111/hel.13091}
}
Kostenlos starten →